Drugs / ChAdOx1 NP+M1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01818362 | Apr 2013 → Nov 2015 | influenza | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChAdOx1 NP+M1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01818362 ↗ |
| Modality | Vaccine | “viral vectored vaccines ChAdOx1 NP+M1 and MVA NP+M1 in heterologous prime-boost regimens” NCT01818362 ↗ |
| Route | Intramuscular | “ChAdOx1 NP+M1 2.5 x 10¹⁰vp intramuscularly.” NCT01818362 ↗ |